Stem cell treatments and Parkinson's disease: Science and misconceptions
Athena Stamper1, Harry Bulstrode1, Roger A Barker1,2
1Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Journal of Parkinson'S Disease
|April 17, 2026
Summary
Parkinson's disease (PD) treatment is evolving beyond drugs. Dopamine cell therapy offers a promising alternative by replacing lost neurons, with ongoing research addressing potential misconceptions.
Area of Science:
- Neuroscience
- Regenerative Medicine
Background:
- Parkinson's disease (PD) involves alpha-synuclein accumulation and loss of dopaminergic neurons.
- Motor symptoms of PD are initially managed by drugs, but efficacy wanes and side effects emerge in later stages.
Purpose of the Study:
- To critically review the historical, current, and future status of dopamine cell therapy for Parkinson's disease.
- To address and clarify potential misconceptions surrounding dopamine cell transplantation.
Main Methods:
- Literature review of dopamine cell therapy research for PD.
- Analysis of historical fetal transplants and current stem cell-derived therapies.
- Discussion of therapeutic progress and challenges.
Main Results:
- Dopamine cell therapy, replacing lost ventral midbrain dopaminergic (vmDA) neurons, is a promising PD treatment.
- Stem cell-derived transplants are progressing through clinical trials.
- The field faces and requires clarification of potential misconceptions.
Conclusions:
- Dopamine cell therapy represents a significant advancement in Parkinson's disease treatment.
- Continued research and clear communication are essential to overcome challenges and misconceptions.
- The review provides a critical summary of dopamine cell therapy's status for PD.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
01:22iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:13Induced Pluripotent Stem Cells
28.7K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.7K
01:06Induced Pluripotent Stem Cells
6.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.4K
01:15Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K